Andrey Gurevich

Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery

Aliya Khan, John P. Bilezikian, Henry G. Bone et al. · European Journal of Endocrinology · 2015 · 79 citations · Full text

<p>Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age</p>

Rossella Parini, Guillem Pintos‐Morell, Julia B. Hennermann et al. · Drug Design Development and Therapy · 2020 · 49 citations · Full text

Prompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis

Derralynn Hughes, Aleš Linhart, Andrey Gurevich et al. · Drug Design Development and Therapy · 2021 · 45 citations · Full text

Urinary Concentrating Defect in Hypothyroid Rats

Melissa A. Cadnapaphornchai, Yang-Wook Kim, Andrey Gurevich et al. · Journal of the American Society of Nephrology · 2003 · 44 citations

Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey Study

Sandro Feriozzi, Aleš Linhart, Uma Ramaswami et al. · Clinical Therapeutics · 2020 · 30 citations · Full text